Forte Biosciences, Inc. — All Filings
582 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
PRE 14A
PREC14A
PRRN14A
REGDEX
REGDEX/A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-008784 | Mar 21, 2025 | Mar 20, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-021463 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-020844 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-000479 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000929638-25-000794 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-021236 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0000947871-25-000158 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001493152-25-006295 | Feb 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000908834-25-000055 | Feb 10, 2025 | — |
| S-8 | S-8 | 0001193125-25-022733 | Feb 7, 2025 | — |
| 8-K | 8-K | 0001193125-25-012236 | Jan 24, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-002699 | Jan 10, 2025 | — |
| 4 | — | 0001415889-25-000142 | Jan 2, 2025 | Jan 1, 2025 |
| 4 | — | 0001415889-25-000141 | Jan 2, 2025 | Jan 1, 2025 |
| DEF 14A | DEF 14A | 0001193125-24-287177 | Dec 31, 2024 | Jan 24, 2025 |
| 424B3 | 424B3 | 0001193125-24-283139 | Dec 20, 2024 | — |
| EFFECT | — | 9999999995-24-003905 | Dec 20, 2024 | — |
| CORRESP | — | 0001193125-24-281362 | Dec 18, 2024 | — |
| UPLOAD | — | 0000000000-24-013819 | Dec 16, 2024 | — |
| S-3 | S-3 | 0001193125-24-278627 | Dec 13, 2024 | — |
| SC 13G/A | FORTE BIOSCIENCES, INC. | 0001193125-24-272446 | Dec 6, 2024 | — |
| 8-K | 8-K | 0001193125-24-269949 | Dec 3, 2024 | — |
| 4 | — | 0001415889-24-027557 | Nov 22, 2024 | Nov 21, 2024 |
| 8-K | 8-K | 0001193125-24-262543 | Nov 20, 2024 | Nov 19, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-258675 | Nov 14, 2024 | — |
| SC 13G/A | FORTE BIOSCIENCES, INC. | 0001193125-24-258524 | Nov 14, 2024 | — |
| 8-K | 8-K | 0001193125-24-258537 | Nov 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-127031 | Nov 14, 2024 | Sep 30, 2024 |
| 4 | — | 0001415889-24-024495 | Oct 2, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024494 | Oct 2, 2024 | Oct 1, 2024 |
| 8-K | 8-K | 0001193125-24-222962 | Sep 20, 2024 | Sep 17, 2024 |
| 4 | — | 0001415889-24-023724 | Sep 19, 2024 | Sep 17, 2024 |
| 3 | — | 0001415889-24-023721 | Sep 19, 2024 | Sep 17, 2024 |
| 3 | — | 0001415889-24-023722 | Sep 19, 2024 | Sep 17, 2024 |
| 4 | — | 0001415889-24-023723 | Sep 19, 2024 | Sep 17, 2024 |
| 8-K | 8-K | 0001193125-24-211066 | Aug 30, 2024 | Aug 27, 2024 |
| 4 | — | 0001415889-24-022000 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-021999 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022002 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022001 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022008 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022009 | Aug 22, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-022010 | Aug 22, 2024 | Aug 20, 2024 |
| 8-K | 8-K | 0001193125-24-205350 | Aug 22, 2024 | Aug 20, 2024 |
| 8-K | 8-K | 0001193125-24-200673 | Aug 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-096988 | Aug 14, 2024 | Jun 30, 2024 |
| DEF 14A | DEF 14A | 0001193125-24-188850 | Jul 30, 2024 | Aug 20, 2024 |
| ARS | ARS | 0001193125-24-188990 | Jul 30, 2024 | Dec 31, 2023 |
| PRE 14A | PRE 14A | 0001193125-24-181642 | Jul 19, 2024 | Aug 20, 2024 |
| 4 | — | 0001415889-24-019123 | Jul 3, 2024 | Jul 1, 2024 |